Cytochrome P450 monooxygenase of Acanthamoeba castellanii participates in resistance to polyhexamethylene biguanide treatment

Acanthamoeba spp. are free-living parasites that can cause severe infections such as granulomatous amoebic encephalitis (GAE) and amoebic keratitis (AK). Polyhexamethylene biguanide (PHMB) is a topical application for AK treatment. However, PHMB is not entirely effective against all Acanthamoeba str...

Full description

Bibliographic Details
Main Authors: Huang Jian-Ming, Ko Pin-Ju, Huang Chao-Li, Wen Po-Wei, Chen Chun-Hsien, Shih Min-Hsiu, Lin Wei-Chen, Huang Fu-Chin
Format: Article
Language:English
Published: EDP Sciences 2021-01-01
Series:Parasite
Subjects:
Online Access:https://www.parasite-journal.org/articles/parasite/full_html/2021/01/parasite210084/parasite210084.html
_version_ 1827776334796947456
author Huang Jian-Ming
Ko Pin-Ju
Huang Chao-Li
Wen Po-Wei
Chen Chun-Hsien
Shih Min-Hsiu
Lin Wei-Chen
Huang Fu-Chin
author_facet Huang Jian-Ming
Ko Pin-Ju
Huang Chao-Li
Wen Po-Wei
Chen Chun-Hsien
Shih Min-Hsiu
Lin Wei-Chen
Huang Fu-Chin
author_sort Huang Jian-Ming
collection DOAJ
description Acanthamoeba spp. are free-living parasites that can cause severe infections such as granulomatous amoebic encephalitis (GAE) and amoebic keratitis (AK). Polyhexamethylene biguanide (PHMB) is a topical application for AK treatment. However, PHMB is not entirely effective against all Acanthamoeba strains or isolates. The mechanisms by which Acanthamoeba protects itself against extreme drug conditions without encystation are still unknown. According to a previous study, cytochrome P450 monooxygenase (CYP450MO) plays an important role in the oxidative biotransformation of numerous drugs related to metabolism. In this study, a CYP450MO fragment was inserted into the pGAPDH-EGFP vector and transfected into Acanthamoeba castellanii. We found that CYP450MO-overexpressing Acanthamoeba had higher survival rates than those of the control cells after PHMB treatment. Moreover, we also found that encystation-related genes such as cellulose synthase I (CSI), encystation-mediating serine proteinase (EMSP), and autophagy-related protein 8 (ATG8) expression levels were not significantly different between Acanthamoeba transfected by pGAPDH-EGFP or pGAPDH-EGFP-CYP450MO. We suggest that Acanthamoeba transfected by pGAPDH-EGFP-CYP450MO may not induce encystation-related genes to resist PHMB treatment. In conclusion, these findings indicate that CYP450MO may be an additional target when PHMB is used for treatment of amoebic keratitis.
first_indexed 2024-03-11T14:03:49Z
format Article
id doaj.art-f8204af917ba44058fc5e31a93cc018d
institution Directory Open Access Journal
issn 1776-1042
language English
last_indexed 2024-03-11T14:03:49Z
publishDate 2021-01-01
publisher EDP Sciences
record_format Article
series Parasite
spelling doaj.art-f8204af917ba44058fc5e31a93cc018d2023-11-02T03:49:36ZengEDP SciencesParasite1776-10422021-01-01287710.1051/parasite/2021074parasite210084Cytochrome P450 monooxygenase of Acanthamoeba castellanii participates in resistance to polyhexamethylene biguanide treatmentHuang Jian-Ming0Ko Pin-Ju1Huang Chao-Li2Wen Po-Wei3Chen Chun-Hsien4Shih Min-Hsiu5Lin Wei-Chenhttps://orcid.org/0000-0001-7223-5931Huang Fu-Chin6Department of Parasitology, College of Medicine, National Cheng Kung UniversityDepartment of Microbiology and Immunology, College of Medicine, National Cheng Kung UniversityInstitute of Tropical Plant Sciences and Microbiology, National Cheng Kung UniversitySchool of Medicine, College of Medicine, National Cheng Kung UniversityInstitute of Basic Medical Sciences, College of Medicine, National Cheng Kung UniversityDepartment of Ophthalmology, National Cheng Kung University HospitalDepartment of Ophthalmology, National Cheng Kung University HospitalAcanthamoeba spp. are free-living parasites that can cause severe infections such as granulomatous amoebic encephalitis (GAE) and amoebic keratitis (AK). Polyhexamethylene biguanide (PHMB) is a topical application for AK treatment. However, PHMB is not entirely effective against all Acanthamoeba strains or isolates. The mechanisms by which Acanthamoeba protects itself against extreme drug conditions without encystation are still unknown. According to a previous study, cytochrome P450 monooxygenase (CYP450MO) plays an important role in the oxidative biotransformation of numerous drugs related to metabolism. In this study, a CYP450MO fragment was inserted into the pGAPDH-EGFP vector and transfected into Acanthamoeba castellanii. We found that CYP450MO-overexpressing Acanthamoeba had higher survival rates than those of the control cells after PHMB treatment. Moreover, we also found that encystation-related genes such as cellulose synthase I (CSI), encystation-mediating serine proteinase (EMSP), and autophagy-related protein 8 (ATG8) expression levels were not significantly different between Acanthamoeba transfected by pGAPDH-EGFP or pGAPDH-EGFP-CYP450MO. We suggest that Acanthamoeba transfected by pGAPDH-EGFP-CYP450MO may not induce encystation-related genes to resist PHMB treatment. In conclusion, these findings indicate that CYP450MO may be an additional target when PHMB is used for treatment of amoebic keratitis.https://www.parasite-journal.org/articles/parasite/full_html/2021/01/parasite210084/parasite210084.htmlacanthamoebapolyhexamethylene biguanidep450 monooxygenaseamoebic keratitis
spellingShingle Huang Jian-Ming
Ko Pin-Ju
Huang Chao-Li
Wen Po-Wei
Chen Chun-Hsien
Shih Min-Hsiu
Lin Wei-Chen
Huang Fu-Chin
Cytochrome P450 monooxygenase of Acanthamoeba castellanii participates in resistance to polyhexamethylene biguanide treatment
Parasite
acanthamoeba
polyhexamethylene biguanide
p450 monooxygenase
amoebic keratitis
title Cytochrome P450 monooxygenase of Acanthamoeba castellanii participates in resistance to polyhexamethylene biguanide treatment
title_full Cytochrome P450 monooxygenase of Acanthamoeba castellanii participates in resistance to polyhexamethylene biguanide treatment
title_fullStr Cytochrome P450 monooxygenase of Acanthamoeba castellanii participates in resistance to polyhexamethylene biguanide treatment
title_full_unstemmed Cytochrome P450 monooxygenase of Acanthamoeba castellanii participates in resistance to polyhexamethylene biguanide treatment
title_short Cytochrome P450 monooxygenase of Acanthamoeba castellanii participates in resistance to polyhexamethylene biguanide treatment
title_sort cytochrome p450 monooxygenase of acanthamoeba castellanii participates in resistance to polyhexamethylene biguanide treatment
topic acanthamoeba
polyhexamethylene biguanide
p450 monooxygenase
amoebic keratitis
url https://www.parasite-journal.org/articles/parasite/full_html/2021/01/parasite210084/parasite210084.html
work_keys_str_mv AT huangjianming cytochromep450monooxygenaseofacanthamoebacastellaniiparticipatesinresistancetopolyhexamethylenebiguanidetreatment
AT kopinju cytochromep450monooxygenaseofacanthamoebacastellaniiparticipatesinresistancetopolyhexamethylenebiguanidetreatment
AT huangchaoli cytochromep450monooxygenaseofacanthamoebacastellaniiparticipatesinresistancetopolyhexamethylenebiguanidetreatment
AT wenpowei cytochromep450monooxygenaseofacanthamoebacastellaniiparticipatesinresistancetopolyhexamethylenebiguanidetreatment
AT chenchunhsien cytochromep450monooxygenaseofacanthamoebacastellaniiparticipatesinresistancetopolyhexamethylenebiguanidetreatment
AT shihminhsiu cytochromep450monooxygenaseofacanthamoebacastellaniiparticipatesinresistancetopolyhexamethylenebiguanidetreatment
AT linweichen cytochromep450monooxygenaseofacanthamoebacastellaniiparticipatesinresistancetopolyhexamethylenebiguanidetreatment
AT huangfuchin cytochromep450monooxygenaseofacanthamoebacastellaniiparticipatesinresistancetopolyhexamethylenebiguanidetreatment